Paclitaxel treatment of ovarian tumor SKOV-3 cells at the sublethal dose in culture renders them more susceptible to lymphokine-activated killer cytolysis

Kim-Sheng Law; Shuen-Kuei Liao

Paclitaxel treatment of ovarian tumor SKOV-3 cells at the sublethal dose in culture renders them more susceptible to lymphokine-activated killer cytolysis

Kim-Sheng Law
, Shuen-Kuei Liao

Graduate Institute of Clinical Medical Sciences

Research output: Contribution to journal › Journal Article › peer-review

Original language	American English
Journal	Cancer Research
Volume	66
Issue number	8
State	Published - 2006

Cite this

@article{dbe9b6d6d45a4790a2314f4678892357,

title = "Paclitaxel treatment of ovarian tumor SKOV-3 cells at the sublethal dose in culture renders them more susceptible to lymphokine-activated killer cytolysis",

author = "Kim-Sheng Law and Shuen-Kuei Liao",

year = "2006",

language = "American English",

volume = "66",

journal = "Cancer Research",

issn = "0008-5472",

publisher = "American Association for Cancer Research Inc.",

number = "8",

}